EOD Primary Tumor

This input is used for staging

Notes

Note: When both the Federation Internationale de Gynecologie et d'Obstetrique (FIGO) stage and extension information on the primary tumor are available, use the extension information to code primary tumor in preference to a statement of FIGO stage.

Default

999

NAACCR Item

NAACCR #772
Code Description SS2018 T
100

Confined to endometrium (stroma)
Invasion of myometrium, NOS
Invasive cancer tumor confined to corpus uteri
Tunica serosa of the visceral peritoneum (serosa covering the corpus)

Limited to uterus, NOS
Localized, NOS

FIGO Stage IA, IB, I [NOS]

Peritoneal Cytology with Primary Tumor for SS2018 T
200

Cervical stromal invasion
Cervix uteri, NOS, but not beyond the uterus
Endocervical glandular involvement only

RE
400

Extension or metastasis within true pelvis

  • Adnexa, NOS
    • Fallopian tube(s)
    • Ligaments (broad, round, uterosacral)
    • Ovary(ies)
  • Parametrium
  • Visceral peritoneum of pelvic organs excluding serosa of corpus uteri

FIGO Stage IIA

RE
450

Parietal serosa of pelvic cavity
Pelvic wall(s)
Ureter
Vagina
Vulva

Described clinically as "frozen pelvis", NOS

FIGO Stage IIB

RE
500

Extension beyond uterus, within pelvis, NOS

FIGO Stage II [NOS]

RE
550

Infiltration of abdominal tissues, one of the following sites

  • Abdominal serosa (visceral or parietal peritoneum of abdomen)
  • Sigmoid colon
  • Small intestine
  • Other abdominal structures

FIGO Stage IIIA

D
600

Infiltration of abdominal tissues (code 550), more than one site

FIGO Stage IIIB

D
650

Abdominal tissues involvement, NOS

FIGO Stage III [NOS]

D
700

Invasion of

  • Bladder wall
  • Bladder, NOS excluding mucosa
  • Rectal wall
  • Rectum, NOS excluding mucosa
RE
750

Invasion of organs in code 700 plus infiltration of any abdominal tissues

Extension to bowel mucosa or bladder (excluding bullous edema)
Cul de sac (rectouterine pouch)

FIGO Stage IVA, IV [NOS]

Further contiguous extension

D
800

No evidence of primary tumor

U
999

Unknown; extension not stated
Primary tumor cannot be assessed
Not documented in patient record

Death Certificate Only

U

(1) Fritz AG, Ries LAG (eds). SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998), National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998

(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). SEER Summary Staging Manual-2000: Codes and Coding Instructions, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.

(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05. American Joint Committee on Cancer (Chicago, IL)

(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. Principles of Cancer Staging. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30

(5) Introduction to Female Reproductive Organs. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 631

(6) Dizon, D.S., Olawaiye, A.B., Mutch, D.G., et al. Corpus Uteri – Sarcoma. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 671-680